Voltar
Artigo Revisado por pares
BIBTEX RIS

MDS-460 Impact of Venetoclax on High-Risk Myelodysplastic Syndromes: A Retrospective Multicenter Analysis of Azacitidine-Venetoclax vs Azacitidine Monotherapy in Mexico

2024; Elsevier BV; Volume: 24; Linguagem: Inglês

10.1016/s2152-2650(24)01363-6

ISSN

2152-2650

Autores

Lyam Carlo Chacon-Rangel, Sergio Rodríguez‐Rodríguez, Juan Luis Ontiveros-Austria, Roberta Demichelis‐Gómez, Andrés Gómez‐De León, Anna Cecilia Rodríguez-Zúñiga, Sergio I. Inclán-Alarcón, Veronica Steffania Corral-Herrera, Nidia Zapata-Canto, Elia Apodaca,

Tópico(s)

Chronic Myeloid Leukemia Treatments

Referência(s)